Miami, Fla. (Oct. 18, 2023) — COPD (chronic obstructive pulmonary disorder) is a chronic, progressive lung disease that affects more than 30 million people in the United States. Shockingly, over 15 million of them remain undiagnosed. COPD comprises several conditions, including chronic bronchitis and emphysema, and can be caused by genetics and irritants like smoke or pollution. In the United States cigarette smoking remains the most common cause, but data suggests that 25-40% of COPD occurs in those who never smoked.
Stigma and the perception that the disease is self-inflicted profoundly impact social support, mental health, self-esteem, and the likelihood of pursuing diagnosis and treatment. Because of public and professional bias, COPD patients are also more likely to experience inappropriate or insufficient care from medical staff, endure uncomfortable patient-doctor interactions, and be refused emergency care and access to oxygen therapy1.
COPD has five main causes:
- Smoking and secondhand smoke
- Early life events like premature birth
- Occupational and environmental causes such as long-term exposure to air pollutants
- Genetics (alpha-1 antitrypsin deficiency)
- Recurrent lung infections, particularly during childhood
This classification of COPD into origin types helps researchers, medical professionals, and the public re-examine assumptions about COPD patients and increases the likelihood that critical research and new treatment options will receive funding and support.
As the prevalence of all types of COPD rises both nationally and globally, it is important to confront any bias and advocate for awareness, early diagnosis, and funding for research, new treatments, and advanced therapies.
This November, you can also get involved in the COPD Foundation’s COPD Awareness Month efforts to increase disease awareness, promote early diagnosis, reduce stigma, and raise funds for critical research.
Studies:
- Mathioudakis AG, Ananth S, Vestbo J. Stigma: an unmet public health priority in COPD. The Lancet Respiratory Medicine. 2021;0(0). doi:https://doi.org/10.1016/S2213-2600(21)00316-7
- Tamondong-Lachica DR, Skolnik N, Hurst JR, et al. GOLD 2023 Update: Implications for Clinical Practice. 2023;Volume 18:745-754. doi:https://doi.org/10.2147/copd.s404690
***
You Might Also Like These From The Good Men Project




Join The Good Men Project as a Premium Member today.
All Premium Members get to view The Good Men Project with NO ADS.
A $50 annual membership gives you an all access pass. You can be a part of every call, group, class and community.
A $25 annual membership gives you access to one class, one Social Interest group and our online communities.
A $12 annual membership gives you access to our Friday calls with the publisher, our online community.
Register New Account
Log in if you wish to renew an existing subscription.
Username
First Name
Last Name
Password
Password Again
Choose your subscription level
- Yearly - $50.00 - 1 Year
- Monthly - $6.99 - 1 Month
Credit / Debit Card PayPal Choose Your Payment Method
Auto Renew
Subscribe to The Good Men Project Daily Newsletter By completing this registration form, you are also agreeing to our Terms of Service which can be found here.Need more info? A complete list of benefits is here.
—
Photo credit: iStock
The post Research Shows That COPD Stigma Hinders Treatment and Harms Mental Health for Patients, and Also Leads to Reduced Funding appeared first on The Good Men Project.
Original Article